S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial

ProShares UltraPro Russell2000 (URTY) News Today

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)
Free URTY Stock Alerts
$38.55
+0.16 (+0.42%)
(As of 04:10 PM ET)
Compare
Stock AnalysisChartHoldingsOwnershipRatings
SourceHeadline
msn.com logoUltraPro Short Russell2000 declares quarterly distribution of $0.3738
msn.com - March 22 at 4:34 PM
investing.com logoProShares UltraPro Russell2000 (URTY)
investing.com - February 29 at 6:46 PM
investing.com logoURTY ETF Stock Price History
investing.com - February 22 at 8:51 PM
msn.com logoUltraPro Russell2000 declares quarterly distribution of $0.0847
msn.com - December 20 at 5:23 PM
thestreet.com logoProShares S&P 500 Bond ETF
thestreet.com - September 14 at 3:50 AM
finance.yahoo.com logoURTY - ProShares UltraPro Russell2000
finance.yahoo.com - June 10 at 6:45 PM
benzinga.com logoProShares UltraPro Russell2000 (ARCA:URTY), Quotes and News Summary
benzinga.com - April 27 at 1:27 PM
msn.com logoTD Cowen Maintains Calix (CALX) Outperform Recommendation
msn.com - April 23 at 1:46 PM
msn.com logoUnusual Call Option Trade in ProShares UltraPro Russell2000 (URTY) Worth $216.00K
msn.com - April 21 at 11:42 PM
msn.com logoEF Hutton Maintains Century Therapeutics (IPSC) Buy Recommendation
msn.com - April 19 at 3:42 AM
nasdaq.com logoFirst Week of February 17th Options Trading For ProShares Trust - ProShares UltraPro S&P500 (UPRO)
nasdaq.com - January 25 at 1:06 PM
msn.com logoProShares Short Russell2000 declares quarterly distribution of $0.0959
msn.com - December 23 at 9:39 AM
morningstar.com logoProShares UltraPro Russell2000 URTY
morningstar.com - November 29 at 12:05 AM
Get ProShares UltraPro Russell2000 News Delivered to You Automatically

Sign up to receive the latest news and ratings for URTY and its competitors with MarketBeat's FREE daily newsletter.

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

URTY Media Mentions By Week

URTY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

URTY
News Sentiment
▼
0.00

0.53
▲
Average

News Sentiment

URTY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

URTY Articles
This Week
▼
0

0
▲
URTY Articles
Average Week

Get ProShares UltraPro Russell2000 News Delivered to You Automatically

Sign up to receive the latest news and ratings for URTY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NYSEARCA:URTY) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The #1 Crypto for 2024
InvestorPlace
SHOCKING Crypto Leak…
Crypto 101 Media